Fluvax not on approved list for infants
CSL Ltd’s probe into 2010’s surge in Fluvax-related febrile events in young children was yet to be finalised, the TGA has noted in its annual update to safety advice on childhood influenza vaccination.
In 2012, four vaccines have been approved for those aged from six months: Influvac (Abbott), Vaxigrip (Sanofi Pasteur), Agrippal (Novartis) and Fluarix (GSK).
Fluvax is approved for use in children older than five years, though the TGA has issued a cautionary note for its use in children aged 5–9 years.
“During the 2010 influenza season, an excess number of febrile reactions and febrile convulsions occurred in children under five years of age following immunisation with… Fluvax,” the TGA said on its website.
“The investigation… is continuing.
“Fluvax is not approved… for use in children under the age of five years, and should only be used in children aged 5–9